Membrane translocation of IL-33 receptor in ventilator induced lung injury

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Yang, Shih Hsing ^a   Lin, Jau Chen ^a   Wu, Shu Yu ^b   Huang, Kun Lun ^b   Jung, Fang ^a   Ma, Ming Chieh ^c   Hsu, Guoo Shyng Wang ^a   Jow, Guey Mei ^c  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 33; TUMOR NECROSIS FACTOR ALPHA; IL33 PROTEIN, RAT; INTERLEUKIN 1 RECEPTOR; ST2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL VENTILATION; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSOL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG CONGESTION; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MECHANICAL VENTILATOR; MORTALITY; NONHUMAN; RAT; TRACHEOSTOMY; VENTILATOR INDUCED LUNG INJURY; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; BRONCHOALVEOLAR LAVAGE FLUID; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN TRANSPORT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL MEMBRANE; CYTOSOL; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-33; LUNG; MALE; PROTEIN TRANSPORT; RATS; RECEPTORS, INTERLEUKIN-1; TRACHEOSTOMY; VENTILATOR-INDUCED LUNG INJURY; VENTILATORS, MECHANICAL;

EID: 84926393107     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121391     Document Type: Article

References (40)

1. Biehl M, Kashiouris MG, Gajic O. Ventilator-induced lung injury: minimizing its impact in patients with or at risk for ARDS. Respir Care. 2013; 58: 927-937. doi: 10.4187/respcare.02347 PMID: 23709192
2. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998; 338: 347-354. PMID: 9449727
3. Uttman L, Bitzen U, De Robertis E, Enoksson J, Johansson L, Jonson B. Protective ventilation in experimental acute respiratory distress syndrome after ventilator-induced lung injury: a randomized controlled trial. Br J Anaesth. 2012; 109: 584-594. doi: 10.1093/bja/aes230 PMID: 22846562
4. Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med. 1998; 157: 294-323. PMID: 9445314
5. Nin N, Penuelas O, de Paula M, Lorente JA, Fernandez-Segoviano P, Esteban A. Ventilation-induced lung injury in rats is associated with organ injury and systemic inflammation that is attenuated by dexamethasone. Crit Care Med. 2006; 34: 1093-1098. PMID: 16484900
6. Brower RG MM, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000; 342: 1301-1308. PMID: 10793162
7. Needham DM, Colantuoni E, Mendez-Tellez PA, Dinglas VD, Sevransky JE, Dennison Himmelfarb CR, et al. Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study. BMJ. 2012; 344: e2124. doi: 10.1136/bmj.e2124 PMID: 22491953
8. Halbertsma FJ, Vaneker M, Scheffer GJ, van der Hoeven JG. Cytokines and biotrauma in ventilator-induced lung injury: a critical review of the literature. Neth J Med. 2005; 63: 382-392. PMID: 16301759
9. Dries DJ, Adams AB, Marini JJ. Time course of physiologic variables in response to ventilator-induced lung injury. Respir Care. 2007; 52: 31-37. PMID: 17194315
10. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Briena A, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA.1999; 282: 54-61. PMID: 10404912
11. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005; 23: 479-490. PMID: 16286016
12. Le Goffic R, Arshad MI, Rauch M, L'Helgoualc'h A, Delmas B, Piquet-Pellorce C, et al. Infection with influenza virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol. 2011; 45: 1125-1132. doi: 10.1165/rcmb.2010-0516OC PMID: 21642589
13. Ho JE, Chen WY, Chen MH, Larson MG, McCabe EL, Cheng S, et al. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling. J Clin Invest. 2013; 123: 4208-4218. doi: 10.1172/JCI67119 PMID: 23999434
14. Miller AM. Role of IL-33 in inflammation and disease. J Inflamm (Lond). 2011; 8: 22. doi: 10.1186/1476-9255-8-22 PMID: 21871091
15. Weinberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, Lee RT. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation. 2003; 107: 721-726. PMID: 12578875
16. Ky B, French B, McCloskey K, Rame JE, McIntosh E, Shahi P, et al. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail. 2011; 4: 180-187. doi: 10.1161/CIRCHEARTFAILURE.110.958223 PMID: 21178018
17. Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ Heart Fail. 2009; 2: 311-319. doi: 10.1161/CIRCHEARTFAILURE.108.833707 PMID: 19808354
18. Sabatine MS, Morrow DA, Higgins LJ, MacGillivray C, Guo W, Bode C, et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation. 2008; 117: 1936-1944. doi: 10.1161/CIRCULATIONAHA.107.728022 PMID: 18378613
19. Kakkar R, Hei H, Dobner S, Lee RT. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem. 2012; 287: 6941-6948. doi: 10.1074/jbc.M111.298703 PMID: 22215666
20. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest. 2007; 117: 1538-1549. PMID: 17492053
21. Institute of Laboratory Animal Research. Commission on Life Sciences, National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, National Academies Press; 1996.
22. Wu SY, Wu CP, Kang BH. Li MH, Chu SJ, Huang KL. Hypercapnic acidosis attenuates reperfusion injury in isolated and perfused rat lungs. Crit Care Med. 2012; 40: 553-559. doi: 10.1097/CCM.0b013e318232d776 PMID: 21946657
23. Aikawa P, Zhang H, Barbas CS, Pazetti R, Correia C, Mauad T, et al. The effects of low and high tidal volume and pentoxifylline on intestinal blood flow and leukocyte-endothelial interactions in mechanically ventilated rats. Respir Care. 2011; 56: 1942-1949. doi: 10.4187/respcare.01183 PMID: 21682956
24. Wu SY, Li MH, Ko FC, Wu GC, Huang KL, Chu SJ. Protective effect of hypercapnic acidosis in ischemia-reperfusion lung injury is attributable to upregulation of heme oxygenase-1. PLoS One. 2013; 8: e74742. doi: 10.1371/journal.pone.0074742 PMID: 24040332
25. Vaporidi K, Francis RC, Bloch KD, Zapol WM. Nitric oxide synthase 3 contributes to ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2010; 299: L150-159. doi: 10.1152/ajplung.00341.2009 PMID: 20453164
26. Dolinay T, Kim YS, Howrylak J, Hunninghake GM, An CH, Fredenburgh L, et al. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med. 2012; 185: 1225-1234. doi: 10.1164/rccm.201201-0003OC PMID: 22461369
27. Tang SE, Wu CP, Wu SY, Peng CK, Perng WC, Kang BH, et al. Stanniocalcin-1 ameliorates lipopolysaccharide-induced pulmonary oxidative stress, inflammation, and apoptosis in mice. Free Radic Biol Med. 2014; 71C: 321-331.
28. Bertok S, Wilson MR, Morley PJ, de Wildt R, Bayliffe A, Takata M. Selective inhibition of intra-alveolar p55 TNF receptor attenuates ventilator-induced lung injury. Thorax. 2012; 67: 244-251. doi: 10.1136/thoraxjnl-2011-200590 PMID: 22156959
29. Amado-Rodriguez L, Gonzalez-Lopez A, Lopez-Alonso I, Aguirre A, Astudillo A, Astudillo A, et al. Antiinflammatory effects of clarithromycin in ventilator-induced lung injury. Respir Res. 2013; 14: 52. doi: 10.1186/1465-9921-14-52 PMID: 23663489
30. Liu D, Yan Z, Minshall RD, Schwartz DE, Chen Y, Hu G. Activation of calpains mediates early lung neutrophilic inflammation in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2012; 302: L370-379. doi: 10.1152/ajplung.00349.2011 PMID: 22140070
31. Belperio JA, Keane MP, Strieter RM. The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced lung injury. In: Didier Dreyfuss GS, Rolf D. Hubmayr, editor. Ventilator-induced lung injury; 2010. pp. 223-265.
32. Xia J, Sun B, He H, Zhang H, Wang C, Zhan Q. Effect of spontaneous breathing on ventilator-induced lung injury in mechanically ventilated healthy rabbits: a randomized, controlled, experimental study. Crit Care. 2011; 15: R244. doi: 10.1186/cc10502 PMID: 22018091
33. Baekkevold ES, Roussigne M, Yamanaka T, Johansen FE, Jahnsen FL, Amalric F, et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol. 2003; 163: 69-79. PMID: 12819012
34. Broch K, Ueland T, Nymo SH, Kjekshus J, Hulthe J, Muntendam P, et al. Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology. Eur J Heart Fail. 2012; 14: 268-277. doi: 10.1093/eurjhf/hfs006 PMID: 22302661
35. Polumuri SK, Jayakar GG, Shirey KA, Roberts ZJ, Perkins DJ, Pitha PM, et al. Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J Immunol. 2012; 189: 50-60. doi: 10.4049/jimmunol.1003554 PMID: 22634618
36. Lingel A, Weiss TM, Niebuhr M, Pan B, Appleton BA, Wiesmann C, et al. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure. 2009; 17: 1398-1410. doi: 10.1016/j.str.2009.08.009 PMID: 19836339
37. Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem. 2007; 282: 26369-26380. PMID: 17623648
38. Yagami A, Orihara K, Morita H, Futamura K, Hashimoto N, Matsumoto K, et al. IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol. 2010; 185: 5743-5750. doi: 10.4049/jimmunol.0903818 PMID: 20926795
39. Luzina IG, Kopach P, Lockatell V, Kang PH, Nagarsekar A, Burke AP, et al. Interleukin-33 potentiates bleomycin-induced lung injury. Am J Respir Cell Mol Biol. 2013; 49: 999-1008. doi: 10.1165/rcmb.2013-0093OC PMID: 23837438
40. Li D, Guabiraba R, Besnard AG, Komai-Koma M, Jabir MS, Zhang L, et al. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J Allergy Clin Immunol. 2014; 134: 1422-1432.e11. doi: 10.1016/j.jaci.2014.05.011 PMID: 24985397